Need Help?

Whole exome sequencing of primary mediastinal large B-cell lymphoma

This dataset contains raw .fastq files of a whole exome sequencing experiment on primary mediastinal large B-cell lymphoma and contains 8 tumor-normal pairs and 14 unpaired tumor samples.

Request Access

DAC policy LRD

DATA ACCESS AGREEMENT These terms and conditions govern access to the managed access datasets (details of which are set out in Appendix I) to which the User Institution has requested access. The User Institution agrees to be bound by these terms and conditions. Definitions Authorised Personnel: The individuals at the User Institution to whom KU Leuven grants access to the Data. This includes the User, the individuals listed in Appendix II and any other individuals for whom the User Institution subsequently requests access to the Data. Details of the initial Authorised Personnel are set out in Appendix II. Data: The managed access datasets to which the User Institution has requested access. Data Producers: KU Leuven and the collaborators listed in Appendix I responsible for the development, organisation, and oversight of these Data. External Collaborator: A collaborator of the User, working for an institution other than the User Institution. Project: The project for which the User Institution has requested access to these Data. A description of the Project is set out in Appendix II. Publications: Includes, without limitation, articles published in print journals, electronic journals, reviews, books, posters and other written and verbal presentations of research. Research Participant: An individual whose data form part of these Data. Research Purposes: Shall mean research that is seeking to advance the understanding of genetics and genomics, including the treatment of disorders, and work on statistical methods that may be applied to such research. User: The principal investigator for the Project. User Institution(s): The Institution that has requested access to the Data. KU Leuven: Katholieke Universiteit Leuven, for the purposes of this Agreement represented by KU Leuven Research & Development, with its offices at Waaistraat 6, box 5105, 3000 Leuven, Belgium, acting on request of Prof. Joris Vermeesch of the Department of Human Genetics. 1. The User Institution agrees to only use these Data for the purpose of the Project (described in Appendix II) and only for Research Purposes. The User Institution further agrees that it will only use these Data for Research Purposes which are within the limitations (if any) set out in Appendix I. 2. The User Institution agrees to preserve, at all times, the confidentiality of these Data. In particular, it undertakes not to use, or attempt to use these Data to compromise or otherwise infringe the confidentiality of information on Research Participants. Without prejudice to the generality of the foregoing, the User Institution agrees to use at least the measures set out in Appendix I to protect these Data. 3. The User Institution agrees to protect the confidentiality of Research Participants in any research papers or publications that they prepare by taking all reasonable care to limit the possibility of identification. 4. The User Institution agrees not to link or combine these Data to other information or archived data available in a way that could re-identify the Research Participants, even if access to that data has been formally granted to the User Institution or is freely available without restriction. 5. The User Institution agrees only to transfer or disclose these Data, in whole or part, or any material derived from these Data, to the Authorised Personnel. Should the User Institution wish to share these Data with an External Collaborator, the External Collaborator must complete a separate application for access to these Data. 6. The User Institution agrees that the Data Producers, and all other parties involved in the creation, funding or protection of these Data: a) make no warranty or representation, express or implied as to the accuracy, quality or comprehensiveness of these Data; b) exclude to the fullest extent permitted by law all liability for actions, claims, proceedings, demands, losses (including but not limited to loss of profit), costs, awards damages and payments made by the Recipient that may arise (whether directly or indirectly) in any way whatsoever from the Recipient’s use of these Data or from the unavailability of, or break in access to, these Data for whatever reason and; c) bear no responsibility for the further analysis or interpretation of these Data. 7. The User Institution agrees to follow the Fort Lauderdale Guidelines (http://www.wellcome.ac.uk/stellent/groups/corporatesite/@policy_communications/documents/web_document/wtd003207.pdf ) and the Toronto Statement (http://www.nature.com/nature/journal/v461/n7261/full/461168a.html). This includes but is not limited to recognising the contribution of the Data Producers and including a proper acknowledgement in all reports or publications resulting from the use of these Data. 8. The User Institution agrees to follow the Publication Policy in Appendix III. This includes respecting the moratorium period for the Data Producers to publish the first peer-reviewed report describing and analysing these Data. 9. The User Institution agrees not to make intellectual property claims on these Data and not to use intellectual property protection in ways that would prevent or block access to, or use of, any element of these Data, or conclusion drawn directly from these Data. 10. The User Institution can elect to perform further research that would add intellectual and resource capital to these data and decide to obtain intellectual property rights on these downstream discoveries. In this case, the User Institution agrees to implement licensing policies that will not obstruct further research and to follow the U.S. National Institutes of Health Best Practices for the Licensing of Genomic Inventions (2005) (https://www.icgc.org/files/daco/NIH_BestPracticesLicensingGenomicInventions_2005_en.pdf ) in conformity with the Organisation for Economic Co-operation and Development Guidelines for the Licensing of the Genetic Inventions (2006) (http://www.oecd.org/science/biotech/36198812.pdf ). 11. The User Institution agrees to destroy/discard the Data held, once it is no longer used for the Project, unless obliged to retain the data for archival purposes in conformity with audit or legal requirements. 12. The User Institution will notify KU Leuven within 30 days of any changes or departures of Authorised Personnel. 13. The User Institution will notify KU Leuven prior to any significant changes to the protocol for the Project. 14. The User Institution will notify KU Leuven as soon as it becomes aware of a breach of the terms or conditions of this agreement. 15. KU Leuven may terminate this agreement by written notice to the User Institution. If this agreement terminates for any reason, the User Institution will be required to destroy any Data held, including copies and backup copies. This clause does not prevent the User Institution from retaining these data for archival purpose in conformity with audit or legal requirements. 16. The User Institution accepts that it may be necessary for the Data Producers to alter the terms of this agreement from time to time. As an example, this may include specific provisions relating to the Data required by Data Producers other than KU Leuven. In the event that changes are required, the Data Producers or their appointed agent will contact the User Institution to inform it of the changes and the User Institution may elect to accept the changes or terminate the agreement. 17. If requested, the User Institution will allow data security and management documentation to be inspected to verify that it is complying with the terms of this agreement. 18. The User Institution agrees to distribute a copy of these terms to the Authorised Personnel. The User Institution will procure that the Authorised Personnel comply with the terms of this agreement. 19. This agreement (and any dispute, controversy, proceedings or claim of whatever nature arising out of this agreement or its formation) shall be construed, interpreted and governed by the laws of Belgium and shall be subject to the exclusive jurisdiction of the Belgian courts. Agreed for User Institution Signature: Name: Title: Date: Principal Investigator I confirm that I have read and understood this Agreement. Signature: Name: Title: Date: Agreed for KULeuven Signature: Name: Esther Buytaert – Paul Van Dun Title: IP Officer – General Manager Date: For acknowledgment: Signature: Name: Joris Vermeesch Title: Professor Date: APPENDIX I – DATASET DETAILS APPENDIX II ––PROJECT DETAILS APPENDIX III –– PUBLICATION POLICY APPENDIX I – DATASET DETAILS (to be completed by the data producer before passing to applicant) Dataset reference (EGA Study ID and Dataset Details) Name of project that created the dataset Names of other data producers/collaborators Specific limitations on areas of research These data are for non-commercial research purposes only. Redistributing these data to any third party is forbidden. Commercial development using these data is forbidden. Commercial entities are forbidden from access to the data. Minimum protection measures required File access: Data can be held in unencrypted files on an institutional compute system, with Unix user group read/write access for one or more appropriate groups but not Unix world read/write access behind a secure firewall. Laptops holding these data should have password protected logins and screenlocks (set to lock after 5 min of inactivity). If held on USB keys or other portable hard drives, the data must be encrypted. APPENDIX II – PROJECT DETAILS (to be completed by the Requestor) Details of dataset requested i.e., EGA Study and Dataset Accession Number Brief abstract of the Project in which the Data will be used (500 words max) All Individuals who the User Institution to be named as registered users Name of Registered User Email Job Title Supervisor* All Individuals that should have an account created at the EGA Name of Registered User Email Job Title APPENDIX III – PUBLICATION POLICY KU Leuven intend to publish the results of their analysis of this dataset and do not consider its deposition into public databases to be the equivalent of such publications. KU Leuven anticipate that the dataset could be useful to other qualified researchers for a variety of purposes. However, some areas of work are subject to a publication moratorium. The publication moratorium covers any publications (including oral communications) that describe the use of the dataset. For research papers, submission for publication should not occur until 36 months after these data were first made available on the relevant hosting database, unless KU Leuven has provided written consent to earlier submission. In any publications based on these data, please describe how the data can be accessed, including the name of the hosting database (e.g., The European Genome-phenome Archive at the European Bioinformatics Institute) and its accession numbers (e.g., EGAS00000000029), and acknowledge its use in a form agreed by the User Institution with KU Leuven.

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
Other

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF00006153215 1651593661677 3.0 GB
EGAF00006153216 1651589943517 3.0 GB
EGAF00006153217 1651587241726 2.9 GB
EGAF00006153218 1651585327632 2.9 GB
EGAF00006153219 1651584720206 2.9 GB
EGAF00006153220 1651585383658 2.9 GB
EGAF00006153221 1651587480742 2.5 GB
EGAF00006153222 1651585153966 2.6 GB
EGAF00006153223 1651586722258 2.3 GB
EGAF00006153224 1651585327632 2.3 GB
EGAF00006153225 1651588802887 2.6 GB
EGAF00006153226 1651585561592 2.6 GB
EGAF00006153227 1651591141762 2.2 GB
EGAF00006153228 1651590663550 2.3 GB
EGAF00006153229 1651584720206 2.7 GB
EGAF00006153230 1651585561592 2.8 GB
EGAF00006153231 1651593722272 2.2 GB
EGAF00006153232 1651584420117 2.3 GB
EGAF00006153233 1651584181622 2.7 GB
EGAF00006153234 1651589341260 2.7 GB
EGAF00006153235 1651585990531 2.2 GB
EGAF00006153236 1651593360384 2.2 GB
EGAF00006153237 1651586183702 2.2 GB
EGAF00006153238 1651584780759 2.2 GB
EGAF00006153239 1651584840314 2.6 GB
EGAF00006153240 1651587421106 2.7 GB
EGAF00006153241 1651588948536 2.3 GB
EGAF00006153242 1651584661152 2.4 GB
EGAF00006153243 1651589286949 2.6 GB
EGAF00006153244 1651589943517 2.6 GB
EGAF00006153245 1651584540146 2.5 GB
EGAF00006153246 1651584900338 2.6 GB
EGAF00006153247 1651591201031 2.6 GB
EGAF00006153248 1651592520097 2.7 GB
EGAF00006153249 1651590721121 3.4 GB
EGAF00006153250 1651591740462 3.4 GB
EGAF00006153251 1651589341260 2.8 GB
EGAF00006153252 1651590786503 2.8 GB
EGAF00006153253 1651589170711 2.4 GB
EGAF00006153254 1651588251300 2.4 GB
EGAF00006153255 1651591141762 2.9 GB
EGAF00006153256 1651592821583 3.0 GB
EGAF00006153257 1651587362109 3.1 GB
EGAF00006153258 1651587421106 3.1 GB
EGAF00006153259 1651586183703 2.6 GB
EGAF00006153260 1651586263426 2.7 GB
EGAF00006153261 1651587541681 2.7 GB
EGAF00006153262 1651587725428 2.7 GB
EGAF00006153263 1651591261814 2.2 GB
EGAF00006153264 1651584840314 2.2 GB
EGAF00006153265 1651591201031 2.3 GB
EGAF00006153266 1651585153966 2.3 GB
EGAF00006153267 1651585202845 3.0 GB
EGAF00006153268 1651588325369 3.1 GB
EGAF00006153269 1651589581563 3.1 GB
EGAF00006153270 1651584243659 3.2 GB
EGAF00006153271 1651584720206 2.3 GB
EGAF00006153272 1651586522763 2.3 GB
EGAF00006153273 1651584780759 2.4 GB
EGAF00006153274 1651593661677 2.5 GB
60 Files (157.9 GB)